Filing Details

Accession Number:
0001209191-15-079482
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-12 07:35:47
Reporting Period:
2015-11-11
Filing Date:
2015-11-12
Accepted Time:
2015-11-12 07:35:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593034 Endo International Plc ENDP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1533149 Suketu Upadhyay C/O Endo International Plc
First Fl, Minerva House, Simmonscourt Rd
Ballsbridge, Dublin 4 L2
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-11-11 1,000 $55.31 12,436 No 4 P Direct
Ordinary Shares Acquisiton 2015-11-11 3,450 $56.68 15,886 No 4 P Direct
Stock Incentive Plan Performance Shares Acquisiton 2015-11-11 4,450 $0.00 51,310 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Stock Incentive Plan Restricted Stock Units (Rsu) 17,740 Direct
Footnotes
  1. This represents the average price per share of ordinary shares that Mr. Upadhyay bought on the open market on November 11, 2015 at prices ranging from $55.00 to $55.70.
  2. This represents the average price per share of ordinary shares that Mr. Upadhyay bought on the open market on November 11, 2015 at prices ranging from $56.21 to $57.01.
  3. The performance shares vest upon the Company achieving certain shareholder return targets over a cumulative 3-year period.
  4. Represents the target number of shares issuable upon achievement of a certain shareholder return target over a cumulative 3-year period, asdetermined by the Registrant's Board of Directors at the end of such three-year period. The ultimate number of shares issued may be the targetnumber or zero, depending on the Registrant's attainment of the shareholder return target over the period.
  5. Pursuant to the Endo International plc Matched Performance Share Unit Program, the Registrant matched Mr. Upadhyay's open market purchases of ordinary shares, subject to certain limitations, which occurred on November 11, 2015, as reported above. These securities were granted to Mr. Upadhyay in consideration of his services as the Executive Vice President and Chief Financial Officer of Endo International plc.
  6. Represents the cumulative target quantity of shares issuable with respect to all 2010 and 2015 Stock Incentive Plan performance sharesoutstanding. The cumulative total is the combination of the target payouts for the current grant and all past grants made under the 2010 StockIncentive Plan and the 2015 Stock Incentive Plan and still outstanding, which are subject to a range of payouts depending on the achievement ofcertain performance metrics as described herein for the current grant and as previously disclosed for all other performance share grants.
  7. Subject to time-based vesting, each restricted stock automatically converts into one (1) ordinary share of Endo International plc.